True Heading NP

True Heading NP
True Heading NP Advance Practice
Showing posts with label Multiple Myeloma. Show all posts
Showing posts with label Multiple Myeloma. Show all posts

Friday, March 20, 2026

Quantitative Immunoglobulins (IgG, IgA, IgM): When to Order, What the Patterns Mean, and the Myeloma Connection


Quantitative Immunoglobulins (IgG, IgA, IgM): When to Order, What the Patterns Mean, and the Myeloma Connection

Recurrent infections, monoclonal spikes, and the difference between too much of one and not enough of everything else.

The Three Immunoglobulins

  • IgG (700–1600 mg/dL): The workhorse—75% of serum immunoglobulins. Provides long-term immunity after infection or vaccination. Crosses the placenta (maternal IgG protects the newborn). Low IgG = increased risk of bacterial infections.
  • IgA (70–400 mg/dL): Mucosal immunity—found in saliva, tears, respiratory and GI secretions. Selective IgA deficiency is the most common primary immunodeficiency (1 in 400–800). Connects to our celiac post (IgA deficiency causes false-negative tTG-IgA).
  • IgM (40–230 mg/dL): The first responder—the initial antibody produced during acute infection. Elevated IgM on infection-specific testing = acute/recent infection. Also the antibody class in Waldenström's macroglobulinemia.

When to Order Quantitative Immunoglobulins

Order When You See
  • Recurrent sinopulmonary infections (2+ pneumonias in a year, 4+ ear infections, chronic sinusitis requiring antibiotics) — evaluate for humoral immunodeficiency
  • Suspected primary immunodeficiency: CVID (common variable immunodeficiency), selective IgA deficiency, X-linked agammaglobulinemia in boys
  • Monoclonal gammopathy workup: SPEP shows an M-spike — quantitative Igs help characterize suppression of uninvolved immunoglobulins (immune paresis)
  • Multiple myeloma monitoring: Suppressed uninvolved Igs (immune paresis) = worse prognosis and higher infection risk
  • Autoimmune hepatitis evaluation: Elevated IgG is part of the diagnostic criteria (with ANA/SMA/anti-LKM)
  • Suspected Waldenström's macroglobulinemia: Markedly elevated IgM with lymphoplasmacytic infiltration
  • Before starting rituximab or other B-cell depleting therapy: Baseline Ig levels for monitoring secondary hypogammaglobulinemia
  • Celiac workup with negative tTG-IgA: Check total IgA to rule out IgA deficiency

The Patterns

PatternIgGIgAIgMThink About
All low (panhypogamma)CVID, X-linked agammaglobulinemia (boys), secondary causes (rituximab, myeloma treatment, nephrotic syndrome protein loss, chronic lymphocytic leukemia)
Selective IgA deficiencyNormal↓↓ (<7 mg/dL)NormalMost common primary immunodeficiency. Usually asymptomatic. Associated with celiac disease, autoimmune conditions, and anaphylaxis to blood products containing IgA.
One Ig markedly elevated, others suppressedOne ↑↑↑, others ↓Monoclonal gammopathy / myeloma. The elevated Ig is monoclonal (M-protein). Confirm with SPEP + immunofixation. Suppression of uninvolved Igs = "immune paresis."
All elevated (polyclonal)Chronic infections (HIV, HCV, TB), autoimmune diseases (SLE, RA, Sjögren's), chronic liver disease (cirrhosis), sarcoidosis
IgG elevated, others normal↑↑NormalNormalAutoimmune hepatitis (type 1), chronic infections, connective tissue diseases
IgM markedly elevatedNormal/↓Normal/↓↑↑↑Waldenström's macroglobulinemia, primary biliary cholangitis (moderate IgM elevation), acute infection (transient)
IgA elevatedNormal↑↑NormalIgA nephropathy, alcoholic liver disease, celiac disease (paradoxically, some celiac patients have elevated IgA), mucosal infections

The Myeloma Connection: Immune Paresis

Critical Pattern

In multiple myeloma, the malignant plasma cells produce massive amounts of one monoclonal immunoglobulin while suppressing normal immunoglobulin production. This means: IgG myeloma = very high IgG (monoclonal) with very low IgA and IgM. IgA myeloma = very high IgA (monoclonal) with very low IgG and IgM. Light chain myeloma = all immunoglobulins may be low (the paraprotein is free light chains only, not measurable as intact Ig). Immune paresis (suppressed uninvolved Igs) is a hallmark of myeloma and is the reason these patients have severe infection susceptibility. IgG <500 mg/dL in a myeloma patient indicates high infection risk and may warrant immunoglobulin replacement therapy.

CVID: The Primary Immunodeficiency to Know

Common Variable Immunodeficiency is the most clinically significant primary immunodeficiency in adults. Diagnostic criteria: markedly reduced IgG (usually <500) with low IgA and/or IgM, impaired vaccine responses, and exclusion of other causes. Patients present with recurrent sinopulmonary infections, bronchiectasis, autoimmune cytopenias, granulomatous disease, and increased lymphoma risk. Mean age of diagnosis: 20–30s. Many patients are misdiagnosed for years before the Ig levels are checked.

Pediatric Note

Neonates have high IgG (transplacental maternal IgG) that wanes by 3–6 months, creating a physiologic nadir. Transient hypogammaglobulinemia of infancy is a delayed maturation of IgG production that self-resolves by 2–4 years—distinguish from true primary immunodeficiency by the child's ability to make specific antibodies to vaccines. X-linked agammaglobulinemia (Bruton's) presents in boys at 6–12 months when maternal IgG wanes, with all Ig classes virtually absent and no circulating B cells.

Selective IgA Deficiency: The Autoimmune Crossover

IgA deficiency (<7 mg/dL with normal IgG and IgM) connects to multiple posts in this series:

  • Celiac disease: IgA deficiency causes false-negative tTG-IgA; always check total IgA with celiac screening
  • Autoimmune associations: Higher prevalence of SLE, RA, thyroiditis, and type 1 diabetes
  • Transfusion risk: Rare patients develop anti-IgA antibodies, causing anaphylaxis to blood products containing IgA. Use IgA-deficient or washed blood products if anti-IgA antibodies are documented.
  • Most IgA-deficient patients are completely asymptomatic and require no treatment.

The Pitfalls

  • Don't confuse quantitative Igs with SPEP: Quantitative Igs measure total amounts. SPEP separates proteins by electrophoretic pattern and detects monoclonal spikes. Both are needed for myeloma workup—they answer different questions.
  • A "normal" IgG in myeloma patients is misleading: The total IgG may appear normal because the monoclonal IgG is included in the total. Subtract the M-spike from the total IgG to get the uninvolved (polyclonal) IgG, which is often severely depleted.
  • Secondary hypogammaglobulinemia is increasingly common: Rituximab, anti-CD38 antibodies (daratumumab), CAR-T therapy, and chronic corticosteroids all cause IgG suppression. Monitor Ig levels in these patients and consider replacement when IgG <400–500 with recurrent infections.
  • Age-dependent norms in children: Pediatric Ig levels change dramatically with age. Use age-specific reference ranges. Neonatal IgG is high (maternal); IgM is low (produced by the infant, not transplacental).

Bottom Line

Quantitative immunoglobulins are essential for evaluating recurrent infections, characterizing monoclonal gammopathies, monitoring immunosuppressive therapy, and diagnosing primary immunodeficiencies. One Ig massively elevated with others suppressed = think myeloma. All Igs low = think CVID or secondary immunodeficiency. Selective IgA deficiency = check for celiac and autoimmune associations. And always use age-appropriate norms in children.

Stay sharp out there.

SPEP, UPEP, Immunofixation, and Free Light Chains: The Myeloma Workup NPs Need to Know

 

SPEP, UPEP, Immunofixation, and Free Light Chains: The Myeloma Workup NPs Need to Know

The dipstick misses light chains. SPEP finds the spike. UPEP catches what spills into the urine. And free light chains changed everything.

This post complements the immunoglobulin levels post and the SPEP section from the autoimmune serologic review. When you suspect a monoclonal gammopathy—whether it's MGUS, multiple myeloma, Waldenström's, or amyloidosis—you need to understand the full diagnostic panel: SPEP, UPEP, immunofixation, and serum free light chains.

The Diagnostic Panel

TestWhat It DoesWhen to Order
SPEP (Serum Protein Electrophoresis)Separates serum proteins by charge. Detects and quantifies an M-spike (monoclonal protein) in the gamma region.Suspected myeloma, MGUS screening, unexplained elevated total protein, unexplained proteinuria, polyclonal gammopathy evaluation
Immunofixation (IFE)Identifies the heavy chain (IgG, IgA, IgM) and light chain (kappa or lambda) type of the monoclonal protein.Confirm and characterize any M-spike seen on SPEP. More sensitive than SPEP for detecting small monoclonal proteins.
Serum Free Light Chains (sFLC)Measures kappa and lambda free light chains and calculates the kappa/lambda ratio.Essential for light chain myeloma, AL amyloidosis, and non-secretory myeloma where SPEP may be negative. Also used for MGUS risk stratification and monitoring.
UPEP (Urine Protein Electrophoresis)Detects monoclonal protein (Bence Jones protein = free light chains) in urine. Requires 24-hour urine collection.Myeloma workup, AL amyloidosis, monitoring light chain excretion post-treatment. Detects the light chains the dipstick misses.
Urine ImmunofixationIdentifies the type of monoclonal protein in urine (kappa vs. lambda).Confirm any monoclonal band on UPEP

Why the Dipstick Misses Myeloma

Critical Connection to Urinalysis Post

As discussed in the urinalysis post, the urine dipstick detects albumin only. It does NOT detect free light chains (Bence Jones protein). A patient with light chain myeloma can have massive proteinuria on a 24-hour collection with a completely negative dipstick. This is why UPEP or urine immunofixation is essential in the myeloma workup. If you suspect myeloma, never rely on the dipstick to assess proteinuria.

The Screening Panel for Suspected Myeloma

Per current IMWG (International Myeloma Working Group) guidelines, the recommended initial workup when you suspect a plasma cell neoplasm is:

  1. SPEP + serum immunofixation
  2. Serum free light chains (kappa and lambda with ratio)
  3. 24-hour UPEP + urine immunofixation

Together, these three tests detect >99% of myeloma cases. Using SPEP alone misses ~15–20% of cases (light chain only and non-secretory myeloma).

When to Suspect Myeloma in Primary Care

Red Flags That Should Trigger the Workup
  • Unexplained anemia (especially normocytic) + elevated total protein or globulin gap
  • Bone pain (especially back, ribs) without clear mechanical cause + anemia
  • Unexplained renal insufficiency (especially with bland urine sediment and proteinuria)
  • Hypercalcemia without obvious cause
  • Markedly elevated ESR (>100 mm/hr) with rouleaux on peripheral smear
  • Recurrent bacterial infections with low immunoglobulins
  • Peripheral neuropathy without other explanation (think AL amyloidosis)
  • Incidental M-spike on SPEP ordered for another reason
  • Pathologic fractures or lytic bone lesions on imaging

MGUS: The Precursor State

Monoclonal Gammopathy of Undetermined Significance (MGUS) is a pre-malignant condition found in ~3% of adults >50. It progresses to myeloma at ~1% per year. MGUS criteria: M-protein <3 g/dL, bone marrow plasma cells <10%, no end-organ damage (CRAB: Calcium elevation, Renal insufficiency, Anemia, Bone lesions). Risk stratification uses: M-protein size, non-IgG isotype, and abnormal free light chain ratio. Low-risk MGUS can be monitored in primary care with annual SPEP, CBC, creatinine, and calcium.

Free Light Chains: The Game-Changer

Serum free light chains revolutionized myeloma diagnostics. Normal kappa/lambda ratio is approximately 0.26–1.65. An abnormal ratio indicates clonal light chain production. FLC is the most sensitive test for detecting light chain myeloma, AL amyloidosis, and non-secretory myeloma—conditions that SPEP and UPEP may miss. The "involved/uninvolved" FLC ratio is also used for monitoring treatment response and detecting early relapse.

The Pitfalls

  • FLC ratio is affected by renal function: In CKD, both kappa and lambda accumulate, and the ratio may be mildly abnormal (kappa/lambda up to 3.1 in renal failure) without a clonal process. Use renal-adjusted reference ranges.
  • SPEP can miss small M-proteins: Immunofixation is more sensitive. If SPEP is negative but clinical suspicion is high, the immunofixation and FLC may still be positive.
  • Don't confuse polyclonal gammopathy with myeloma: A broad-based elevation in the gamma region = polyclonal (autoimmune disease, chronic infection). A narrow spike = monoclonal (MGUS, myeloma, Waldenström's). Immunofixation distinguishes them definitively.
  • Urine collection errors: UPEP requires a complete 24-hour collection. Incomplete collections underestimate proteinuria. Some centers now accept a random urine immunofixation for screening, but 24-hour quantification is still needed for monitoring.
  • IgA myeloma is harder to quantify on SPEP: IgA M-proteins migrate in the beta region and may be missed or under-quantified. Quantitative IgA and FLC are important adjuncts for monitoring IgA myeloma.

Bottom Line

The myeloma workup requires three tests: SPEP with immunofixation, serum free light chains, and 24-hour UPEP with urine immunofixation. Using any one alone will miss cases. The urine dipstick is blind to light chains. Free light chains are the most sensitive test for light chain disease. And a monoclonal spike on SPEP in a patient over 50 is MGUS until proven otherwise—but it requires monitoring because 1% per year will progress to myeloma.

Stay sharp out there.

Featured Post

Diabetes in 2026: The Ominous Octet Just Got a New Member

  NP CHRONICLES Clinical Deep Dive Diabetes in 2026: The Ominous Octet Just Got a New Member A CME update from Harvar...